2025 North America Allergy Immunotherapy Revenue Opportunities Report
Description
The 2025 North America Allergy Immunotherapy Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Immunotherapy by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North American allergy immunotherapy market are ALK-Abelló, Stallergenes Greer, Allergy Therapeutics, and HollisterStier Allergy. ALK-Abelló leads the market with a strong portfolio of sublingual immunotherapy (SLIT) tablets and subcutaneous immunotherapy (SCIT) products, focusing on expanding approvals and innovation. Stallergenes Greer, which acquired Allergy Therapeutics in 2023, is recognized for advancing personalized immunotherapy solutions and expanding its market reach through strategic partnerships and acquisitions. Allergy Therapeutics, now part of Stallergenes Greer, develops next-generation injectable immunotherapies and contributes significantly to the industry's innovative pipeline. HollisterStier Allergy is noted for investing in biologic allergy treatment research, complementing the market presence of the other three leaders.
In North America, these companies dominate a competitive market valued in the hundreds of millions USD and growing due to the rising incidence of allergic diseases and ongoing product innovation. The market growth is supported by regulatory approvals, increased patient awareness, and development of new delivery technologies such as connected devices for immunotherapy administration. Hospital and online pharmacies play a crucial role in product distribution, with expanded access driving immunotherapy adoption. Emerging treatments, including peptide vaccines and recombinant allergens, along with digital health platforms, further sustain this growth trend amid challenges such as cost and patient compliance.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Immunotherapy by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North American allergy immunotherapy market are ALK-Abelló, Stallergenes Greer, Allergy Therapeutics, and HollisterStier Allergy. ALK-Abelló leads the market with a strong portfolio of sublingual immunotherapy (SLIT) tablets and subcutaneous immunotherapy (SCIT) products, focusing on expanding approvals and innovation. Stallergenes Greer, which acquired Allergy Therapeutics in 2023, is recognized for advancing personalized immunotherapy solutions and expanding its market reach through strategic partnerships and acquisitions. Allergy Therapeutics, now part of Stallergenes Greer, develops next-generation injectable immunotherapies and contributes significantly to the industry's innovative pipeline. HollisterStier Allergy is noted for investing in biologic allergy treatment research, complementing the market presence of the other three leaders.
In North America, these companies dominate a competitive market valued in the hundreds of millions USD and growing due to the rising incidence of allergic diseases and ongoing product innovation. The market growth is supported by regulatory approvals, increased patient awareness, and development of new delivery technologies such as connected devices for immunotherapy administration. Hospital and online pharmacies play a crucial role in product distribution, with expanded access driving immunotherapy adoption. Emerging treatments, including peptide vaccines and recombinant allergens, along with digital health platforms, further sustain this growth trend amid challenges such as cost and patient compliance.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
